Abstract Atypical lesions of a presumably idiopathic inflammatory demyelinating origin present quite variably and may pose diagnostic problems. The subsequent clinical course is also uncertain. We, therefore, wanted to clarify if atypical idiopathic inflammatory demyelinating lesions (AIIDLs) can be classified according to previously suggested radiologic characteristics and how this classification relates to prognosis. Searching the databases of eight tertiary referral centres we identified 90 adult patients (61 women, 29 men; mean age 34 years) with C1 AIIDL. We collected their demographic, clinical and magnetic resonance imaging data and obtained follow-up ( 
Introduction
Multiple sclerosis (MS) is the most frequent idiopathic inflammatory demyelinating disorder of the brain and has been associated with a quite characteristic lesion appearance on magnetic resonance imaging (MRI) [1, 2] . Rarely patients also present with uncommon or atypical lesions for which-nevertheless-an idiopathic inflammatory origin is presumed [3] . These lesions may occur as a singular event, or at onset or during the course of a relapsing-remitting disease which suggests some relation with ''classical'' MS. The frequency and intensity of this relation is not yet fully clear, however. To acknowledge the absence of more exact pathophysiologic insights and to avoid a priori classification, we, therefore, have suggested the rather neutral term atypical idiopathic inflammatory demyelinating lesions (AIIDLs) [4] . Some of these lesions are commonly referred to as tumefactive lesions [5] . Others have been associated with presumed severe ''MS variants'' like Schilder's, Marburg's or Baló's diseases [6] . Except for Baló's disease, however, these ''variants'' do not have a specific image appearance [7] which is prohibitive when attempting to derive prognostic implications.
The AIIDLs also often pose a diagnostic problem by mimicking tumours or infectious inflammatory processes including abscesses. Furthermore their size and appearance tend to imply significant damage to the brain with severe functional deficits, although this has not been substantiated. Thus, AIIDLs have received attention both in the pathologic and imaging literature but this has been limited mostly to individual case reports or small patient series. As a consequence, no commonly agreed classification of AIIDLs has been produced, and their prognostic implications have remained unclear.
In a first step, we reviewed the literature and proposed an MRI classification based on specific morphologic characteristics of AIIDLs [4] . These appeared to cluster into four subtypes, i.e., infiltrative, megacystic, Baló-like, and ring-like lesions, with only the latter being quite frequent in ''classical'' MS. While this has expanded the notion of MRI features which may be associated with an idiopathic inflammatory disorder-an important aspect for differential diagnostic considerations-we could not derive useful information on the subsequent disease course. This was due to limited clinical information and follow up, and reporting bias was a potentially important limitation. We, therefore, undertook a careful retrospective review of patients with AIIDLs, who had been observed and followed in centres of the Magnetic Resonance Network in MS (MAGNIMS) in order to investigate how the occurrence of such lesions and of AIIDL subtypes relates to patients' prognosis and an MS like course of the disease. In this effort we also wanted to test the applicability of suggested MRI classification for the description of AIIDLs.
Methods

Patient cohort
We searched the databases of six centres of the MAGNIMS group and of two collaborating MS centres in Brazil and Mexico for patients with C1 atypical lesion on MRI. Patients had to be C18 years and the idiopathic inflammatory demyelinating aetiology of the lesion had to be confirmed by comprehensive diagnostic work-up including long-term follow-up (FU) in most cases.
Clinical and MRI data
Patients' charts and FU documentation were systematically reviewed at the individual centres using a standardised questionnaire. Special attention was given to the mode of clinical presentation, the course of disease including previous and further relapses, and patients' disability as measured by the Expanded Disability Status Scale (EDSS) score [8] .
The MRIs were reviewed centrally for number and type of AIIDLs following proposed classification [4] (Table 1 ; Fig. 1) , unaware of the clinical data. We also recorded the additional presence of MS-typical lesions and of contrast enhancement. Follow-up scans were interpreted in a similar manner, first separately, and then in a side-by-side comparison with preceding investigations. 
Results
We identified a total of 90 patients (61 women, 29 men) with at least one AIIDL. Their age ranged from 18 to 64 years (mean 34 years). The infiltrative lesion type was observed most frequently (n = 35) followed by ring-like (n = 16), megacystic (n = 16), and Baló-like (n = 10) lesions (Table 2 ). In 13 patients, imaging characteristics were mixed or not clearly attributable to one of the a priori defined lesion types. For the sake of comparison these were included as ''other'' in the analysis. The distribution of AIIDL subtypes was quite uniform throughout the participating centres, except for a rather high number of megacystic lesions seen in patients contributed by the Sao Paulo center. Likewise patients' mean age and gender distribution was quite comparable between centres. The AIIDL associated symptoms constituted the first clinical attack in 70 (78 %) patients. Table 3 shows the clinical presentations according to AIIDL subtypes. Motor and multifocal symptoms dominated. A single AIIDL was seen in 72 patients, while the remaining 18 patients showed two or more AIIDLs.
The overall prevalence of additional MS-typical lesions was 53 % (48 of 90 patients). Considering only patients showing an AIIDL together with a first attack, the prevalence of lesions suggestive of MS was 44 % (31 of 70 patients). In contrast, 85 % (17 of 20) patients with a previous attack exhibited MS-typical lesions in addition to the AIIDL (Table 3 ). In patients with Baló-like lesions, 83 % showed marked clinical improvement from the initial attack or fully recovered, whereas only 23 % of patients with infiltrative lesions had a good clinical outcome (EDSS B1.0). In the other AIIDL subgroups, good recovery was found in 45 % with megacystic and 49 % with ring-like lesion appearance.
Clinical FU was available from a total of 77 patients. The duration of FU ranged from 0.5 to 8 years (Table 4) . Two-thirds or more of the patients experienced no further attack within the observational period, except for the group with ring-like AIIDLs who had further attacks in 62 % of the followed patients. The EDSS at last FU ranged between 1.5 and 3.5 in the subgroups. A FU MRI was obtained in 69 patients. A further AIIDL developed only rarely. Interestingly, this lesion was different in appearance from the initial lesion type in four of six instances. On the other hand, new MS-typical lesions developed in 29 (42 %) patients.
To investigate the role of coexisting MS typical lesions on a patient's prognosis, we looked separately at the groups of patients with and without such lesions at presentation with an AIIDL. As can be seen from Table 5 , new MS typical lesions developed in both subgroups, but with a higher frequency in patients who had such lesions already at onset (52.6 vs. 29.0 %; p \ 0.01). Further attacks were also significantly more frequent in patients with MS typical lesions at presentation with an AIIDL (41.3 vs. 9.6 %; p \ 0.005).
Discussion
Our study on patients with AIIDLs who were seen in tertiary referral centres addresses several important aspects. The majority of AIIDLs presented with one of the four appearances as suggested in our review of the literature [4] . This is also supported by the quite similar distribution of AIIDL subtypes seen within the participating centres. In the present series we found a higher number of lesions of the infiltrative type as would have been expected from our review, but clearly a more rigorous and widespread collection of AIIDL cases would be needed to define the exact proportion and distribution of AIIDL subtypes. Noteworthy, some lesions could not be classified into any of the four subtypes. This was mostly because of a mixture of morphologic features or because AIIDLs did not completely meet the predefined classification characteristics at the time of the MRI examination. Further attacks, n (%) 2 (13. Regarding lesion occurrence, it is of interest that AIIDLs were associated with a first clinical attack in most instances. Otherwise more than half of the patients also showed MS-typical lesions on their MRI scans of the brain. This is quite comparable to the experience in the series of Lucchinetti et al. [5] . Multiple lesions were present in 70 % of their series and 46 % fulfilled the Barkhof criteria prior to biopsy.
Our FU data also indicate that the appearance of any of the AIIDL subtypes, including non-classifiable AIIDLs, need not indicate a highly active relapsing course of the disease. In fact the rate of further relapses was rather low in all subtypes and ranged from 23 to 35 %, with a higher frequency of 62 % only in patients presenting with ringlike lesions. This is not unexpected as ring-like lesions are also frequently seen during the course of patients with a firm diagnosis of MS [9] . Furthermore, some difference in the length of FU between AIIDL subgroups has to be considered when interpreting these data. Importantly, further relapses developed primarily in those individuals with coexisting MS typical lesions at presentation with an AI-IDL and, thus, these appear to be an indicator regarding further clinical activity. Interestingly, this is similar to the observation in patients with a clinically isolated syndrome in general who have an increased likelihood for ongoing disease in the presence of other MS-typical lesions [10] .
Overall the course of the disease was not specifically active in patients whose first clinical symptoms were caused by an AIIDL. The sometimes quite extensive lesions themselves, however, caused quite profound deficits in some instances although the recovery was good in the majority of patients. This resulted in a wide range of the EDSS at onset and also explains the rather high mean EDSS at last FU found in all subtypes considering the short-term disease duration. Presentation with an AIIDL thus does not appear to predict a bad long-term prognosis. This is in line with other recent reports of a series on different subtypes of AIIDLs [11, 12] and provides useful information regarding patient counselling. Yet other investigators have made different observations [13] . Ethnicity and age are among the various factors that may account for this. Thus we did not include children in our series as they are known to more often present with quite extensive and diagnostically challenging immune-mediated lesions of the CNS [14] . Furthermore, this diversity in findings may come from differences in AIIDLs themselves which is not sufficiently reflected by the term ''tumefactive'' alone. We,therefore, suggest a more detailed classification of AIIDLs such as used in present analysis.
On FU MRI there was a high likelihood for the appearance of new MS-typical lesions when present already at the initial exam. Such lesions developed in more than half of those patients and in all AIIDL subtypes. In contrast, new lesion development was seen in only 28 % of patients with no MS-typical lesions at baseline. The rate of further AIIDLs was low. They developed in only six of the 77 patients and in three instances had a different lesion characteristic than before.
Unfortunately, our study does not provide further and more firm information regarding therapy. For treatment of the acute attack, high-dose steroids were used in most instances, partly with a late response [15] . Plasmapheresis was used in some cases. If and to what extent long-term immunomodulatory strategies were effective or differed in efficacy because of the presence of an AIIDL cannot be answered from our series. Only half of the patients were on immunomodulatory treatment, and the rate of further attacks was low with or without such treatment. Another limitation stems from the inability to systematically examine the possible contribution of more advanced or other imaging techniques to the differential diagnosis of AIIDLs. Several suggestive features for AIIDLs have been reported on diffusion-weighted imaging, perfusion-weighted imaging and magnetic resonance spectroscopy, but also on cerebral angiography and positron emission tomography in individual cases and small series and would need confirmation [7, [16] [17] [18] [19] [20] . Finally, we cannot exclude that, despite careful search in the individual data banks, some cases with AIIDLs were missed due to the retrospective nature of data collection which also precluded more homogenous FU information. This may also have been the reason for the relatively low rate of ring-like lesions as many of those probably have not been considered AIIDLs anymore [9] .
In conclusion, our findings confirm the occurrence of predominantly four characteristic types of AIIDLs. These lesion patterns should be considered in the differential diagnostic work-up of patients over a wide age range. The oldest of our patients with an AIIDL was 64 years old. In addition, there also exists a smaller number of AIIDLs not meeting these characteristics with similar implications. The concomitant presence of MS-typical lesions is an important hint for differential diagnostic clarification and such lesions should be actively searched for to avoid unnecessary biopsies. More than half of individuals who were available for FU remained free of further attacks over a mean of 4 years. Regarding prognostic implications there appears to be no great difference between AIIDL subtypes except for ring-like AIIDLs which are already an accepted finding within the spectrum of classical MS lesions. The likelihood of having or developing MS appears to be quite closely linked to the presence (higher likelihood of MS) or absence (lower likelihood of MS) of additional clinically silent MRI lesions typical for demyelination.
